Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Alzheimer's Medication Trials

Aventura, Florida

Alzheimer's medication trials in Aventura, FL

7 Alzheimer's medication studies are recruiting participants at sites in Aventura as of November 17, 2026, according to ClinicalTrials.gov. Alzheimer's Medication Trials can help you understand your options and connect with a study team.

Call (888) 927-5916
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Aventura at a glance

  • 7 studies are recruiting at a site in Aventura.
  • By phase: Phase 2 (2), Phase 2/3 (1), Phase 3 (3), Phase 4 (1).
  • By sponsor: industry (7).
  • Most recent update to one of these records: November 17, 2026.

Studies recruiting in Aventura

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    VIN-Julie Schwartzbard
    Registry record
    NCT06976216 · updated
  2. ACP-204 in Adults With Alzheimer's Disease Psychosis

    • Phase 2/3
    • Ages 55 to 95
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Study site
    Humanity Clinical Research Corp
    Registry record
    NCT06159673 · updated
  3. Flutemetamol F 18 Injection Formulation Comparison

    • Phase 2
    • Ages 50 to 110
    • All sexes
    Sponsor
    GE Healthcare
    Study site
    Visionary Investigator Network
    Registry record
    NCT07873463 · updated
  4. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    VIN - Aventura
    Registry record
    NCT07589595 · updated
  5. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Visionary Investigators Network
    Registry record
    NCT07011745 · updated
  6. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    VIN - Aventura
    Registry record
    NCT07602582 · updated
  7. A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

    • Phase 4
    • Ages 50 and older
    • All sexes
    Sponsor
    Alpha Cognition, Inc
    Study site
    First Choice Neurology - Aventura Neurologic Associates
    Registry record
    NCT07633470 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Aventura, FL on ClinicalTrials.gov.

Ask about studies near Aventura

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

Alzheimer's Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5916

or send a short form

How should we reach you?

Call